FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine and can be used to alleviate a side effect of treatment with solifenacin in a patient. Therapeutically effective amount of extended release solifenacin or a pharmaceutically acceptable salt thereof and a therapeutically effective amount of pilocarpine or a pharmaceutically acceptable salt thereof, are used. Pilocarpine or a pharmaceutically acceptable salt thereof, is administrated to the patient about 2 hours after the administration of solifenacin or a pharmaceutically acceptable salt thereof. Method of treating a patient suffering from overactive bladder and a method of alleviating a side effect of treatment with solifenacin in a patient, which is dry mouth are also proposed.
EFFECT: group of inventions allows alleviating a side effect of treatment with solifenacin in a patient.
17 cl, 5 tbl, 3 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| THERAPY FOR TREATING DISEASE | 2006 |
|
RU2435610C2 |
| PHARMACEUTICAL COMPOSITIONS | 2011 |
|
RU2612022C2 |
| METHODS AND COMPOSITIONS FOR TREATING HYPERHIDROSIS | 2016 |
|
RU2718906C2 |
| APPLICATION OF 10-[(3R)-1-AZABICYCLO[2,2,2]OCT-3-YLMETHTYL]-10H-PHENOTHIAZINE FOR PREPARING DRUG SELECTIVELY INHIBITING MUSCARINE RECEPTORS M1L, M2 AND M3 | 2007 |
|
RU2449794C2 |
| METHOD OF TREATMENT OF ENURESIS USING (S)-OXYBUTYNIN AND (S)-DESETHYLOXYBYTININ | 1997 |
|
RU2195276C2 |
| THERAPEUTIC AGENT FOR TREATING FIBROMYALGIA | 2009 |
|
RU2464023C2 |
| DERIVATIVES OF ARYL- OR HETEROARYLAZOLYL CARBINOLS FOR TREATING INCONTINENCE OF URINE | 2002 |
|
RU2308268C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING URINARY DISTURBANCES | 2012 |
|
RU2497504C1 |
| NOVEL METHODS | 2008 |
|
RU2484821C2 |
| METHOD FOR TREATMENT OF PAIN OR INTERSTITIAL CYSTITIS, USING INDOLE COMPOUND | 2019 |
|
RU2791025C2 |
